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Early reoperations in chronic subdural 
hematoma
AbstrAct
Background: The recurrence rate of chronic subdural hematoma (cSDH) is high and early reoperation is often 
required. 
Aim: The aim of this study was to evaluate prognostic factors for early reoperation of chronic subdural hematomas 
(cSDH) treated by classical and minimally invasive approach.
Materials and Methods: We retrospectively analyzed the medical history of 355 cSDH patients treated with 
formal craniotomy and minimally invasive burr hole craniostomy. We determined the potential predictors of early 
reoperations.
Results: A total of 33 (9.3%) patients required early reoperation. Those patients more often underwent craniotomies 
instead of burr hole craniostomies (36.4% vs. 62.7%, p < 0.01) and took steroids before hospitalization (3.0% vs. 
0.3%, p = 0.04) than non-reoperated patients. Patients who had surgery on the right side were less likely to be 
reoperated (51.9% vs. 33.3%, p = 0.04). On multivariate analysis the frontal (OR = 5.284, 95% CI: 1.293–21.76, 
p = 0.019) and large craniotomy (OR = 2.297, 95% CI: 1.004–5.258, p = 0.048) remained independent risk 
factors for early reoperation of cSDH. 
Conclusions: Neurosurgeons should consider the evacuation of a cSDH with help of minimally invasive burr 
hole craniostomy in most of the cases, as well as avoid large and frontal and craniotomies in order to prevent 
early reoperation of cSDH.
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Introduction 
Chronic subdural hematoma (cSDH) is a common 
problem in neurosurgical practice, which accounts for 
about 10% of all intracranial hematomas [1]. It occurs 
typically in older patients [2–3] and its incidence varies 
between 1.72 and 20.6 per 100.000 individuals per year 
[2]. It is usually caused by traumatic event [4]. Initial 
management of cSDH remains controversial and might 
be either conservative or surgical [5–6]. In terms of sur-
gical treatment, there are two main techniques in use. 
First of them is the group of minimally invasive methods 
of burr hole craniostomy and twist-drill craniostomy [7]. 
Alternatively regular craniotomy is performed which, if 
necessary, might be accompanied by membranectomy 
[8]. Among surgically treated patients, about 52% to 
77% result with good functional outcome [5, 9–11] and 
3-month mortality rate is reported between 8% and 22% 
[10, 12–13]. One of the predictors of poor treatment 
outcome is cSDH recurrence [3, 14]. The rate of this 
phenomenon is very diverse among different studies 
and varies between 10 and 33% [15–17]. Potential pre-
dictors of cSDH recurrence have been widely analyzed 
by other researchers and many factors were identified. 
The most common was age, bilateral cSDH, antico-
agulants intake and approach related complications 
[18–22]. On the other hand most of authors analyze total 
recurrence rate regardless of the time period, neglecting 
early, acute reoperations of cSDH. Predictors of early 
reoperations by means of reoperation during the same 
hospitalization are still unknown. Therefore, we decided 
to analyze which factors might be associated with con-
ditions leading to early reoperations in cSDH treatment 
with emphasis on minimally invasive techniques. 
Materials and Methods
We retrospectively analyzed 355 patients hospital-
ized between January 2013 and December 2016 with 
CT-confirmed cSDH who underwent surgical proce-
dures. Upon admission patients were assessed using 
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Glasgow Coma Scale (GCS). From their medical record 
we obtained detailed medical history which included 
previous diseases and current medications. We also 
obtained blood test results taken within 24 hours before 
the surgery together with details concerning operation 
such as its date, type and side and whether the doctor 
who performed the surgery and their assistant were 
specialists in neurosurgery. 
If the patient was qualified for minimally invasive pro-
cedure, the two burr hole surgery with saline irrigation 
and subdural or subperiosteal drain was performed. 
Closed drainage system was left for 72 hours. The 
choice of drain compartment was based on personal 
surgeon decision depending on the width of the sub-
dural space.
Patients with large, nonhomogenous hematoma 
with membranes were qualified for craniotomy with 
membranectomy. A typical Redon drainage was placed 
in craniotomized patients in subperiosteal space. Type 
of craniotomy was defined by anatomical localization 
and surface area. Surface area was defined by number 
of convexity bones that were contained in craniotomy. 
Early reoperation was defined as reoperation that 
occurred during the same hospitalization due to a pri-
mary neurosurgical condition. 
Study protocol was approved by local University Eth-
ical Committee (protocol number KBET/152/B/2012). All 
subjects signed an informed consent form.
To perform the statistical analysis, we used c2 test for 
proportional values and t-student test and Mann-Whit-
ney U test as appropriate for continuous variables. To 
determine the potential predictors of reoperation after 
cSDH operation we used univariate and multivariate 
logistic regression analysis. P-values < 0.05 were 
considered to be statistically significant. Threshold of 
p-value < 0.1 was used to qualify date to multivariate 
logistic regression analysis. Forward logistic regression 
analysis was followed by backwards logistic regression 
analysis. To perform all statistical analysis we used 
STATISTICA v. 10 for Windows (Statsoft, Poland).
results
Our study group consisted of 355 patients and 
94 (26.47%) of them were females. Mean age of study 
group was 70.22 ± 15.61 years and mean GCS upon 
admission was 13.14 ± 3.62. A total of 33 (9.29%) un-
derwent early reoperation. The indication for revision 
surgery was hematoma reaccumulation with or without 
neurological deterioration or incomplete removal with 
persisting clinical and radiological signs of mass effect. 
For revision surgery craniotomy was performed.
Details concerning medical history, current medi-
cations and blood test results are presented in Tab. 1.
Reoperated patients significantly less often under-
went minimally invasive procedures (burr hole with sub-
dural or subperiosteal drainage) (36.36% vs. 62.73%; 
p < 0.01). They also less often had surgery on the right 
side (33.33 vs. 51.86%; p = 0.04). Reoperated patients 
more often took steroids (3.03% vs. 0.31%; p = 0.04) 
prior to surgery. The also more often underwent primary 
surgery with assisting specialist (24.24% vs. 9.32%; 
p < 0.01). Details concerning surgery are presented 
in Tab. 2. Distribution of type of surgery is presented 
in Figure 1. 
After adjustment for possible confounders, classical 
approaches like frontal craniotomy (OR: 5.284; 95% 
CI: 1.293–21.576; p = 0.019) and fronto-temporo-pa-
rietal craniotomy (OR: 2.297; 95% CI: 1.004–5.258; 
p = 0.048) remained independently associated with 
higher risk of early unplanned reoperation. Minimally 
invasive approach via burr holes (OR: 0.365; 95% CI: 
0.172–0.774; p < 0.01) remained independently asso-
ciated with lower risk of early unplanned reoperation. 
Results of multivariate logistic regression analysis are 
presented in Tab. 3.
Discussion
We established cSDH early reoperation rate at 
around 9% in entire group of patients. Similar rates were 
observed by Yamamoto et al. and Lee et al. [18–19]. 
Jung et al. observed recurrence of cSDH in about 13% 
of patients included in their study [22] and Torihashi in 
about 17% [17]. In their review of 48 studies, Weigel 
et al. established that cSDH recurrence rate varied 
between 10 and 33% [15]. 
In our study we determined the impact of minimally 
invasive approach on reoperation rate in treatment of 
cSDH. Burr hole craniostomy instead of conventional 
craniotomy were independently associated with a lower 
risk of cSDH recurrence. On the contrary, our study 
showed independent association between higher risk of 
cSDH early reoperations and large (fronto-temporo-pa-
rietal) or frontal craniotomy. Hematomas demanding 
wide craniotomy usually are larger and contain thick-
ened or calcified membranes [23]. Furthermore larger 
craniotomy put the patients at higher risk of surgical 
complications: cortical injury, intracerebral hemorrhage, 
seizures, surgical site infection, significant blood loss 
[17, 20, 23]. Similar association had been observed 
in Schulz et al. study [24]. Also, in Weigel et al. study, 
morbidity was higher for patients who underwent crani-
otomies [15]. This is in comparison to the Hamilton et 
al. study, in which they found no differences between 
these surgical techniques in terms of cSDH recurrence 
[25]. Craniotomy (12.3%) has a higher morbidity com-
paring to minimally invasive approaches like burr hole 
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Table 1. Details concerning medical history, medications and blood test results in reoperated and non-reoperated 
group
Reoperation (n = 33) No reoperation (n = 322) p-value
Age [years] ± SD 68.27 ± 17.69 70.42 ± 15.4 0.45
Glasgow Coma Scale ± SD 13.50 ± 3.21 13.10 ± 3.67 0.72
Female gender [%] 30.3 26.09 0.60
Medical history
Hypertension [%] 39.39 31.37 0.35
Diabetes mellitus [%] 9.09 16.77 0.25
Cigarette smoking [%] 21.21 12.42 0.16
Alcohol abuse [%] 12.12 21.74 0.19
Ischemic heart disease [%] 9.09 2.8 0.056
History of heart attack [%] 6.06 4.97 0.79
History of ischemic stroke [%] 6.06 6.52 0.92
Atrial fibrillation [%] 9.09 12.11 0.61
Lungs diseases [%] 3.03 1.86 0.65
Hyperthyroidism [%] 0 0.62 0.65
Hypothyroidism [%] 0 3.73 0.26
Hypercholesterolemia [%] 0 4.97 0.19
Current medications
Acetylsalicylic acid [%] 6.06 7.14 0.82
Beta-blockers [%] 12.12 13.04 0.88
Angiotensin-converting-enzyme inhibitors [%] 15.15 11.80 0.57
AT2-blockers [%] 0 1.24 0.52
Calcium channel blockers [%] 3.03 5.9 0.49
Diuretics [%] 12.12 15.22 0.63
Steroids [%] 3.03 0.31 0.04
Antidiabetic therapy [%] 0 4.66 0.21
Insulin [%] 6.06 5.28 0.85
Heparin [%] 0 1.55 0.47
Anticoagulants [%] 6.06 11.49 0.34
Nitrates [%] 0 2.80 0.33
Statins [%] 0 3.73 0.26
Blood test results preceding surgery
Red Blood Cells count [103/μl] ± SD 3.97 ± 0.73 3.96 ± 0.68 0.93
White Blood Cells count [103/μl] ± SD 9.80 ± 4.40 9.19 ± 4.10 0.46
Platelets count [103/μl] ± SD 216.04 ± 80.19 225.84 ± 94.11 0.60
Activated Partial Prothrombin Time [s] ± SD 12.13 ± 1.95 12.01 ± 1.98 0.77
International Normalized Ratio ± SD 29.28 ± 4.36 33.2 ± 8.72 0.08
Creatinine [μmol/l] ± SD 1.11 ± 0.13 1.34 ± 0.71 0.12
Glucose [mmol/l] ± SD 83.32 ± 68.17 80.34 ± 36.5 0.74
Mean Corpuscular Volume [μm3] ± SD 5.6 ± 1.6 7.41 ± 14.41 0.56
Mean Corpuscular Hemoglobin [pg] ± SD 90.57 ± 9.70 90.02 ± 5.42 0.65
Mean Corpuscular Hemoglobin Concentration [g/dl] ± SD 30.82 ± 3.16 30.43 ± 2.09 0.39
Urea [mmol/l] ± SD 34.06 ± 1.41 33.8 ± 1.24 0.31
Sodium [mmol/l] ± SD 7.13 ± 6.93 6.83 ± 4.58 0.78
Potassium [mmol/l] ± SD 140.12 ± 3.05 139.24 ± 4.70 0.36
Prothrombin Time [s] ± SD 4.03 ± 0.59 4.12 ± 0.56 0.46
Hematocrit [%] ± SD 12.32 ± 0.92 14.64 ± 6.70 0.16






























Figure 1. Distribution of type of surgery in reoperated and non-reoperated group; ** – p-value < 0.01






Surgery during weekend [%] 24.24 32.61 0.33
„On call” hours of surgery [%] 30.30 27.64 0.75
Bone flap removal [%] 75.76 84.78 0.17
Operating specialist 33.33 37.27 0.66
Assisting specialist 24.24 9.32 < 0.01
Approach
Fronto-temporo-parietal [%] 30.3 17.39 0.07
Fronto-parietal [%] 3.03 4.04 0.78
Parieto-occipital [%] 0 0.31 0.75
Temporal [%] 0 0.31 0.75
Parietal [%] 6.06 2.80 0.30
Frontal [%] 9.09 2.80 0.056
Minimally invasive burr hole craniostomy [%] 36.36 62.73 < 0.01
Right side [%] 33.33 51.86 0.04
Left side [%] 63.64 54.35 0.31
Table 3. Results of multivariate logistic regression analysis. OR – Odds Ratio, CI – Confidence Interval
Risk factor OR 95% CI p-value
Frontal craniotomy 5.284 1.293 – 21.576 0.019
Fronto-temporo-parietal craniotomy 2.297 1.004 – 5.258 0.048
Minimally invasive burr hole craniostomy 0.365 0.172 – 0.774 < 0.01
Assisting specialist 3.433 1.389 – 8.489 < 0.01
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(3.8%) and twist drill craniostomy (3.0%) but similar cure 
and mortality rates [15]. The fact that burr hole surgery 
carries lower risk of complications can be explained by 
the fact that this procedure is much less invasive and 
also easier to perform than a craniotomy. Association 
between less invasive procedure and lower risk of 
recurrence can also be proved by Taussky et al. study 
which showed that the number of burr holes can be an 
independent risk factor of cSDH recurrence [26]. 
While surgery is a gold standard for treating cSDH, 
than burr hole is the most commonly performed ap-
proach to treat it. Although there is no class I evidence 
showing which technique is superior, and the decision is 
based mainly on the house rules the burr hole technique 
remains the best option for treating cSDH. This proposal 
results from its beneficial cure to complications ratio. 
Although twist drill craniostomy is often performed as 
bedside intervention with only local anesthesia the high-
er risk of infection is an important issue to consider. [23]
The recurrence rate of burr hole craniostomy 
(11.7%) is much lower than craniotomy (19.4%) and 
another minimally invasive technique, twist drill cra-
niostomy (28.1%) as showed Ducruet et al. study [27].
The lower recurrence rate was shown to be achieved 
when the drainage system was used as a part of burr 
hole craniostomy procedure [28]. This may also corre-
spond to lower risk of early reoperation while using this 
minimally invasive technique in our study. Furthermore 
to reduce the cortical surface injury the drain was in-
serted subdurally only in case if it was judged as safe, 
otherwise was placed in subperiosteal space. The safe 
use of extracranial drain was proofed by Yadav et al [29].
An interesting finding of our study was independent 
association between right side cSDH and lower risk 
of its early recurrence needing reoperation. Influence 
of cSDH side on recurrence rate had been analyzed 
before by a few researchers [16–17, 29–30]. However, 
none of them found any significant correlation in terms 
of this predictor. Only bilateral cSDH was proved to be 
associated with higher risk of recurrence [16, 21]. Chen 
et al. in their study suggested that cSDH on the left side 
might increase the risk of post-operative seizures [30]. 
As seizures were proved to be an independent risk 
factor of cSDH recurrence by Kong et al., these facts 
might explain abovementioned correlation [31]. 
We also discovered association between preopera-
tive chronic steroids intake and early cSDH recurrence. 
Influence of steroids intake had been analyzed before 
in terms of cSDH recurrence [16], as corticosteroids 
treatment had been considered as therapy for both 
alternative and adjuvant to surgical treatment of cSDH 
[4]. Few researchers have found no association be-
tween cSDH recurrence and steroids intake [32–34]; 
however, in their meta-analysis Almenawer et al. found 
that steroids treatment adjuvant to surgical treatment 
was associated with higher mortality among patients 
with cSDH [4]. This might be consistent with our results.
Our study was limited by fact that obtained data 
come from single neurosurgical facility experience. 
Further research should be performed as multi-center 
study. Despite those limitations, we were able to analyze 
possible complications requiring early reoperation after 
chronic subdural hematoma surgeries during 4-year 
period. 
conclusions 
Factors such as frontal craniotomy, fronto-tempo-
ro-parietal craniotomy, previous steroids intake and 
assisting specialist can be associated with a higher 
risk of early cSDH recurrence needing reoperation 
and should be taken into consideration while planning 
treatment of patients with cSDH and during postoper-
ative care. On the other hand, patients who undergo 
minimally invasive procedures instead of craniotomies 
and surgery on the right side due to cSDH treatment 
are at lower risk of early reoperation. 
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